|
LIN54 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.1431999791256E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.20820003896216E-09 |
| Normal-vs-Stage2 |
2.178100E-04 |
| Normal-vs-Stage3 |
1.045800E-02 |
| Normal-vs-Stage4 |
1.082170E-01 |
| Stage1-vs-Stage2 |
4.446600E-01 |
| Stage1-vs-Stage3 |
2.189400E-01 |
| Stage1-vs-Stage4 |
4.435600E-01 |
| Stage2-vs-Stage3 |
6.252400E-01 |
| Stage2-vs-Stage4 |
7.116000E-01 |
| Stage3-vs-Stage4 |
9.783000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19230003647885E-09 |
| Normal-vs-AfricanAmerican |
1.28720000003302E-06 |
| Normal-vs-Asian |
9.942900E-03 |
| Caucasian-vs-AfricanAmerican |
7.793600E-01 |
| Caucasian-vs-Asian |
7.643200E-01 |
| AfricanAmerican-vs-Asian |
8.270000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.92600421459133E-11 |
| Normal-vs-Female |
7.048000E-04 |
| Male-vs-Female |
9.823800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.10840000000645E-05 |
| Normal-vs-Extreme_Weight |
7.7108996965336E-10 |
| Normal-vs-Obese |
7.368000E-04 |
| Normal-vs-Extreme_Obese |
6.46610000000214E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.345000E-01 |
| Normal_Weight-vs-Obese |
4.122800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.064600E-01 |
| Extreme_Weight-vs-Obese |
4.185700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.683400E-01 |
| Obese-vs-Extreme_Obese |
3.938600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.281540E-02 |
| Normal-vs-Age(41-60Yrs) |
2.4752999999933E-05 |
| Normal-vs-Age(61-80Yrs) |
4.16644496681329E-12 |
| Normal-vs-Age(81-100Yrs) |
4.74510000003647E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.213400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.028300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.396000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.980700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.542800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.452000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.12170273069978E-11 |
| Normal-VS-Type2 PRCC |
1.400090E-04 |
| Normal-VS-KIRP CIMP |
3.213800E-01 |
| Normal-VS-Unclassified PRCC |
7.445800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.930000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.511600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.690500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.943400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.657800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.862000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.8734099999973E-05 |
| Normal-vs-N1 |
1.064070E-02 |
| Normal-vs-N2 |
2.810800E-01 |
| N0-vs-N1 |
3.295600E-01 |
| N0-vs-N2 |
9.434800E-01 |
| N1-vs-N2 |
6.834200E-01 |
|
|
